Avidity Biosciences
RNA
$24.36
Share price
2.22%
Change (1 day)
40.48%
Change (1 year)
Categories
Number of shares outstanding for Avidity Biosciences (RNA)
Number of shares outstanding as of April 2024 : 74,097,000
According to Avidity Biosciences's latest financial reports and stock price the company's current number of shares outstanding is 74,097,000. At the end of 2023 the company had 74,097,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Avidity Biosciences from 2019 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 74.09 M | 29.32% |
| 2022 | 57.29 M | 142.7% |
| 2021 | 23.6 M | -36.97% |
| 2020 | 37.45 M | 81.1% |
| 2019 | 20.68 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 5,647,000,000 | 7,521.09% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 2,636.95% | 🇬🇧 UK |
 Sarepta Therapeutics
SRPT | 88,889,000 | 19.96% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | 75,377,997 | 1.73% | 🇺🇸 USA |
 Fate Therapeutics
FATE | 98,568,012 | 33.03% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | 1,242,000 | -98.32% | 🇺🇸 USA |
 Acceleron Pharma XLRN | 53,824,600 | -27.36% | 🇺🇸 USA |
 Catalyst Pharmaceuticals CPRX | 106,568,137 | 43.82% | 🇺🇸 USA |